Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 1 minute read Pharma Industry News CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial Taiwanese pharma company Center Laboratories (CenterLab) said that its anti-diabetic drug candidate CS02 has met the primary endpoint… bypharmanewsdailyJuly 11, 2020